Evidence map›Paper›PMID 40556814›Full record

ArticleACS nanoscience Au2025

Cellular Uptake of Hybrid PLGA-Lipid Gadolinium Nanoparticles Functionalized for Magnetic Resonance Imaging of Pancreatic Adenocarcinoma Cells.

Alessandro Amaolo, Hanieh Sadeghi, Carla Carrera, Sergio Padovan, Fabio Carniato, Enza Di Gregorio, Giuseppe Ferrauto

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS nanoscience Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alessandro AmaoloMolecular Imaging Center, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Via Nizza 52, Torino 10126, Italy.
Hanieh SadeghiMolecular Imaging Center, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Via Nizza 52, Torino 10126, Italy.ORCID https://orcid.org/0009-0008-2370-7523
Carla CarreraMolecular Imaging Center, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Via Nizza 52, Torino 10126, Italy.ORCID https://orcid.org/0000-0002-1571-7851
Sergio PadovanMolecular Imaging Center, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Via Nizza 52, Torino 10126, Italy.
Fabio CarniatoDipartimento di Scienze e Innovazione Tecnologica, Università degli Studi del Piemonte Orientale, Via Teresa Michel 11, Alessandria 15121, Italy.ORCID https://orcid.org/0000-0002-6268-1687
Enza Di GregorioMolecular Imaging Center, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Via Nizza 52, Torino 10126, Italy.
Giuseppe FerrautoMolecular Imaging Center, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Via Nizza 52, Torino 10126, Italy.ORCID https://orcid.org/0000-0003-4937-6140

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic adenocarcinoma (PDAC) presents significant diagnostic challenges, necessitating improved imaging techniques. Here, we develop hybrid poly-(lactic-

Indexed as

magnetic resonance imagingmolecular imagingnanoparticlespancreatic cancerPLGAtheranostic

Identifiers

PMID40556814
PMCPMC12183577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.